Why the study?
Does the use of evidence-based therapies reduce the risk of ischemic stroke after an acute myocardial infarction in patients with diabetes mellitus?
Population
173,233 unselected patients with an acute myocardial infarction, including 33,503 patients with diabetes…
Comparison
Evidence-based therapies vs Patients without diabetes mellitus; and temporal…
Design
Cohort
Follow-up
1 year
Authors
Loading...
Stroke incidence after AMI declined over time in diabetes; supports temporal gains but leaves causal roles of therapies open.
Does the use of evidence-based therapies reduce the risk of ischemic stroke after an acute myocardial infarction in patients with diabetes mellitus?
The risk of ischemic stroke after an acute myocardial infarction in patients with diabetes has significantly decreased over time, largely driven by the increased use of evidence-based therapies including reperfusion, aspirin, P2Y12 inhibitors, and statins.
Jakobsson et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: